Elevance Health Inc. stock underperforms Tuesday when compared to competitors
Elevance Health Inc. closed $174.10 below its 52-week high ($567.26), which the company achieved on September 3rd.
Elevance Health price target raised to $512 from $501 at Barclays
Barclays raised the firm’s price target on Elevance Health (ELV) to $512 from $501 and keeps an Overweight rating on the shares post the Q4 ...
Hosted on MSN1mon
Is Elevance Health Stock Underperforming the Dow?
The stock has lagged behind the Dow over the longer term as well. ELV stock has declined 16.7% on a YTD basis and 18.5% over the past 52 weeks compared to DOWI’s 18.8% gains in 2024 and 23.9% ...
Dow Jones Today: Stocks Surge in Late Trading to Extend Winning Streak; S&P 500 Hits Record Closing High
Stocks closed solidly higher on Thursday for the fourth straight session as investor optimism about the Trump administration continues to run high.
Elevance Health (ELV) Receives a Buy from Truist Financial
In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Elevance Health (ELV – Research Report), with a ...
Nasdaq1mon
Dow Jones Industrial Average Can’t Shake UnitedHealth Woes Even with Interest Rate Cut Hopes
The Dow Jones Industrial Average (DJIA) is slipping today despite investors preparing for the upcoming Federal Reserve meeting. Traders have been waiting for this meeting as it will be a major ...
MarketWatch25d
Elevance Health Inc. stock underperforms Monday when compared to competitors
Shares of Elevance Health Inc. ELV shed 0.61% ... with the S&P 500 Index SPX falling 1.07% to 5,906.94 and Dow Jones Industrial Average DJIA falling 0.97% to 42,573.73. This was the stock's ...